Details of the Drug
General Information of Drug (ID: DMJP5YF)
| Drug Name |
Levodropropizine
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
Levodropropizine; 99291-25-5; (S)-3-(4-Phenylpiperazin-1-yl)propane-1,2-diol; Levdropropizine; (-)-Dropropizine; Levotuss; Danka; Levodropropizina; Levodropropizinum; (2S)-3-(4-phenylpiperazin-1-yl)propane-1,2-diol; Rapitux; UNII-3O31P6T4G3; Levodropropizinum [INN-Latin]; Levodropropizina [INN-Spanish]; 99291-24-4; Levodropropizine [INN]; DF 526; CHEBI:82722; 3O31P6T4G3; S(-)-3-(4-Phenylpiperazin-1-yl)propane-1,2-diol; (-)-(S)-3-(4-Phenyl-1-piperazinyl)-1,2-propanediol; Levodropropizine (INN); 1,2-Propanediol, 3-(4-phenyl-1-pipe
|
||||||||||||||||||
| Indication |
|
||||||||||||||||||
| ATC Code |
|
||||||||||||||||||
| Drug Type |
Small molecular drug
|
||||||||||||||||||
| Structure |
![]() |
||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||
| Chemical Identifiers |
|
||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||
| Drug Pharmacogenomic Perturbation (DPP)NEW | Click to Jump to the Detailed DPP Information of This Drug | ||||||||||||||||||
| Drug ADMET Endpoint Profile (DAE)NEW | Click to Jump to the Detailed DAE Information of This Drug | ||||||||||||||||||

